Tag: Amedisys
DOJ sues UnitedHealth to block Amedisys deal
November 20, 2024HME News Staff
WASHINGTON – The U.S. Department of Justice, together with the attorneys general of Maryland, Illinois, New Jersey and New York, has filed a civil antitrust lawsuit to block UnitedHealth Group’s proposed $3.3 billion acquisition of Amedisys because it would eliminate competition between the two companies.
Since UnitedHealth’s acquisition of LHC Group, a competitor of Amedisys, in 2023, UnitedHealth and Amedisys have been two of the largest home health and hospice providers...
Option Care-Amedisys acquisition falls through
June 26, 2023HME News Staff
BANNOCKBURN, Ill. – Option Care Health announced today that it has terminated its $3.6 billion merger with Amedisys, just weeks after Optum made an unsolicited bid for the home health care provider.
Option Care Health says it will receive a $106 million termination fee.
"While we are disappointed in this outcome, Option Care Health has a long track record of delivering value for our shareholders," said John C. Rademacher, president and CEO. "We take a...
Focus on post-acute care circles HME
June 19, 2023Liz Beaulieu, Editor
Recently, I wrote about the news that Humana has contracted with AdaptHealth and Rotech Healthcare to provide HME products and services to its Medicare Advantage HME members.
Now, another giant health care company is making waves in the HME industry: Optum, which has been a subsidiary of UnitedHealthcare since 2011 and which earlier this year bought LHC Group for a reported $5.4 billion.
LHC Group has 30,000 employees delivering home health, hospice, home- and community-based services,...
In brief: Optum makes play for Amedisys, FDA updates Philips report count
June 7, 2023HME News Staff
EDEN PRAIRIE, Minn., and BATON ROUGE, La. – Optum has submitted an all-cash proposal to buy Amedisys, despite Option Care Health announcing last month that it was merging with the home health and hospice provider.
“Amedisys’ commitment to quality and care innovation within the home, and the patient-first culture of its people, combined with Optum’s deep value-based care expertise can drive meaningful improvement in the health outcomes and experiences of more patients...
Optum makes play for Amedisys
June 5, 2023HME News Staff
EDEN PRAIRIE, Minn., and BATON ROUGE, La. – Optum has submitted an all-cash proposal to the board of directors of Amedisys to combine with the company in an effort to advance value-based care.
“Amedisys’ commitment to quality and care innovation within the home, and the patient-first culture of its people, combined with Optum’s deep value-based care expertise can drive meaningful improvement in the health outcomes and experiences of more patients at lower costs, leading...
Option Care, Amedisys scale up
May 5, 2023Theresa Flaherty, Managing Editor
BANNOCKBURN, Ill., and BATON ROUGE, La. – The merger of Option Care Health and Amedisys creates a home care giant with projected annual revenue of $6.2 billion that’s primed to serve a $100 billion addressable market for everything from prevention and maintenance care to acute and post-acute care to end-of-life care.
Option Care, the nation's largest independent provider of home and alternate site infusion services, and Amedisys, a leading provider of home health, hospice...
Option Care Health, Amedisys to merge
May 3, 2023HME News Staff
BANNOCKBURN, Ill. and BATON ROUGE, La., - Option Care Health, Inc., the nation's largest independent provider of home and alternate site infusion services, and Amedisys, Inc., a leading provider of home health, hospice and high-acuity care, have entered into an agreement to merge.
The all-stock transaction values Amedisys at approximately $3.6 billion, including the assumption of net debt.
Combining Amedisys' home health, hospice, palliative,...
Option Care Health, Amedisys offer antibody therapy
January 6, 2021HME News Staff
BATON ROUGE, La., and BANNOCKBURN, Ill. – Option Care Health has partnered with Amedisys, a provider of home health, hospice and personal care, to provide COVID antibody infusion therapy in skilled nursing and assisted living facilities. In December, the National Home Infusion Association announced a pilot program with Operation Warp Speed and the Department of Health and Human Services to expand access to Bamlanivimab, which is being used to treat mild to moderate COVID-19 in adults and pediatrics...